Comparison Overview

Vera Therapeutics, Inc.

VS

Genentech

Vera Therapeutics, Inc.

2000 Sierra Point Pkwy, 1200, Brisbane, California, US, 94005
Last Update: 2026-03-27
Between 750 and 799

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for serious immunological diseases to improve patients’ lives. Fraud alert for potential candidates for positions at Vera: your personal information and online safety are a top priority for us. At Vera Therapeutics, recruiters will only direct candidates to apply through our official career page at https://veratx.com/careers/. We will never request payments, ask for financial account information or sensitive information such as social security numbers. If you are unsure if a message is from Vera Therapeutics, please email [email protected].

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 175
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Genentech

1 Dna Way, South San Francisco, California, US, 94080
Last Update: 2026-04-01
Between 750 and 799

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 18,082
Subsidiaries: 50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/veratx.jpeg
Vera Therapeutics, Inc.
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/genentech.jpeg
Genentech
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Vera Therapeutics, Inc.
100%
Compliance Rate
0/4 Standards Verified
Genentech
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Vera Therapeutics, Inc. in 2026.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Genentech in 2026.

Incident History — Vera Therapeutics, Inc. (X = Date, Y = Severity)

Vera Therapeutics, Inc. cyber incidents detection timeline including parent company and subsidiaries

Incident History — Genentech (X = Date, Y = Severity)

Genentech cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/veratx.jpeg
Vera Therapeutics, Inc.
Incidents

No Incident

https://images.rankiteo.com/companyimages/genentech.jpeg
Genentech
Incidents

No Incident

FAQ

Genentech company demonstrates a stronger AI Cybersecurity Score compared to Vera Therapeutics, Inc. company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Genentech company has disclosed a higher number of cyber incidents compared to Vera Therapeutics, Inc. company.

In the current year, Genentech company and Vera Therapeutics, Inc. company have not reported any cyber incidents.

Neither Genentech company nor Vera Therapeutics, Inc. company has reported experiencing a ransomware attack publicly.

Neither Genentech company nor Vera Therapeutics, Inc. company has reported experiencing a data breach publicly.

Neither Genentech company nor Vera Therapeutics, Inc. company has reported experiencing targeted cyberattacks publicly.

Neither Vera Therapeutics, Inc. company nor Genentech company has reported experiencing or disclosing vulnerabilities publicly.

Neither Vera Therapeutics, Inc. nor Genentech holds any compliance certifications.

Neither company holds any compliance certifications.

Genentech company has more subsidiaries worldwide compared to Vera Therapeutics, Inc. company.

Genentech company employs more people globally than Vera Therapeutics, Inc. company, reflecting its scale as a Biotechnology Research.

Neither Vera Therapeutics, Inc. nor Genentech holds SOC 2 Type 1 certification.

Neither Vera Therapeutics, Inc. nor Genentech holds SOC 2 Type 2 certification.

Neither Vera Therapeutics, Inc. nor Genentech holds ISO 27001 certification.

Neither Vera Therapeutics, Inc. nor Genentech holds PCI DSS certification.

Neither Vera Therapeutics, Inc. nor Genentech holds HIPAA certification.

Neither Vera Therapeutics, Inc. nor Genentech holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.